Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline ( (GB:GSK) ) just unveiled an announcement.
GSK has launched the fourth tranche of its previously announced £2 billion share buyback programme, initiating a repurchase of up to £0.45 billion of its ordinary shares. The latest tranche, conducted under a non‑discretionary agreement with BNP Paribas, will run from 17 February to 24 April 2026, with all shares bought held as treasury stock.
The programme is designed to return excess capital to shareholders, reduce the company’s share capital and is expected to enhance earnings per share, reinforcing GSK’s capital allocation strategy. By continuing the buyback within existing regulatory and shareholder authorities, GSK underscores confidence in its financial position and provides an additional route of value return alongside dividends for investors.
The most recent analyst rating on (GB:GSK) stock is a Buy with a £24.50 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Neutral.
The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GSK is a global biopharma company focused on uniting science, technology and talent to develop medicines and vaccines that help people get ahead of disease. The company operates across major pharmaceutical and vaccine markets worldwide, targeting a broad range of therapeutic areas and public health needs.
Average Trading Volume: 8,707,514
Technical Sentiment Signal: Buy
Current Market Cap: £87.35B
For an in-depth examination of GSK stock, go to TipRanks’ Overview page.